Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-30 @ 11:44 AM
Study NCT ID:
NCT00310856
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2006-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
Sponsor:
Novartis Vaccines
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
V59P9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None